Lung Cancer Medicines from India
Non-small cell lung cancer (NSCLC) is often treated with targeted therapy when specific mutations (e.g. EGFR) are present, or with chemotherapy. Molecular testing helps the doctor choose the right drug. This page lists generic lung cancer medicines from India available at U-India. The information is for reference and does not replace medical advice.
EGFR targeted therapy
- Osidok (Osimertinib) — third-generation EGFR-TKI.
- Erlocip (Erlotinib) — EGFR-TKI.
- Geftinat (Gefitinib) — EGFR-TKI.
- Xovoltib (Afatinib) — second-generation EGFR-TKI.
Chemotherapy
- Paclikast (Paclitaxel) — taxane.
- Cycokast (Cisplatin) — platinum-based.
This information is educational and does not replace medical advice. All medicines are prescription-only.